kanamycin sulfate

kanamycin sulfate (KANTREX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

KANTREX is a marketed brand name for kanamycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

kanamycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.